New Assay Expands INDIGO’s GPCR Portfolio and Supports Development of Next-Generation CNS-Related Therapeutics STATE ...

Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that nine oral and poster ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...

Significantly higher repigmentation rates seen for pediatric patients receiving JAK inhibitor versus topical tacrolimus therapy combined with 308-nm excimer laser ...

To celebrate earning a major creator milestone, a friendly but competitive football challenge unfolds between siblings. The event combines personal achievement with playful rivalry. A mix of shooting, ...

Please provide your email address to receive an email when new articles are posted on . The 6-month risk of acne was higher among those receiving a JAK inhibitor vs. a Th2 cytokine inhibitor (4.93% vs ...

We systematically searched PubMed, the Cochrane Library, and Web of Science from inception through March 1, 2025, for randomized controlled trials (RCTs) comparing P-CAB, PPI, and/or placebo for the ...

Tom Brady left the NFL several years ago. But even now, three years later, he seems to make headlines just as often as he did as a player. He does have his hand in quite a few pies after all. And one ...

Berkeley signed a five-year, no-bid contract with Community Conservation Centers to process the city’s recycled materials in 2021. An audit found the deal should have been subject to competitive ...